![](/img/cover-not-exists.png)
BRAFV600 inhibitor discontinuation after complete response in advanced melanoma. A retrospective analysis of 16 patients
Vanhaecke, C., Deilhes, F., Chanal, J., Regnier-Rosencher, E., Boitier, F., Boulinguez, S., Avril, M.-F., Guégan, S., Dupin, N., Aractingi, S., Meyer, N., Kramkimel, N.Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.15345
Date:
January, 2017
File:
PDF, 94 KB
english, 2017